459 is the total number of securities Endurant Capital Management LP has owned. The longest Endurant Capital Management LP has owned a single stock is 31 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| LH | LABORATORY CORP AMER H... | 11 | 3 | 0.10% | 3.01% | 8.70% | Q4 2014 | Q2 2023 | 31 |
| ANTM | ELEVANCE HEALTH INC | 12 | 1 | 0.26% | 2.76% | 8.82% | Q4 2014 | Q3 2023 | 29 |
| BDX | BECTON DICKINSON & CO | 16 | 2 | 0.08% | 2.98% | 9.77% | Q4 2014 | Q2 2023 | 28 |
| MCK | MCKESSON CORP | 17 | 1 | 0.13% | 1.78% | 4.41% | Q4 2014 | Q1 2023 | 27 |
| ABC | CENCORA INC | 7 | 1 | 0.14% | 1.65% | 5.86% | Q4 2014 | Q3 2023 | 26 |
| HOLX | HOLOGIC INC | 14 | 1 | 0.11% | 2.17% | 7.53% | Q4 2014 | Q3 2023 | 24 |
| JNJ | JOHNSON & JOHNSON | 8 | 1 | 0.15% | 1.86% | 5.46% | Q4 2014 | Q4 2021 | 24 |
| ZBH | ZIMMER HLDGS INC | 10 | 1 | 0.23% | 2.48% | 7.51% | Q4 2014 | Q3 2023 | 23 |
| BSX | BOSTON SCIENTIFIC CORP | 17 | 1 | 0.20% | 2.01% | 5.47% | Q4 2014 | Q3 2023 | 22 |
| DVA | DAVITA INC | 17 | 1 | 0.07% | 1.91% | 4.93% | Q4 2014 | Q1 2021 | 22 |
| CNC | CENTENE CORP DEL | 9 | 1 | 0.16% | 1.64% | 5.61% | Q3 2015 | Q1 2023 | 21 |
| TMO | THERMO FISHER SCIENTIF... | 15 | 1 | 0.31% | 2.88% | 6.30% | Q4 2014 | Q3 2023 | 20 |
| HUM | HUMANA INC | 7 | 1 | 0.11% | 1.76% | 5.17% | Q4 2014 | Q3 2023 | 20 |
| CI | THE CIGNA GROUP | 10 | 9 | 0.37% | 3.73% | 7.12% | Q4 2018 | Q3 2023 | 19 |
| OCUL | OCULAR THERAPEUTIX INC | 14 | 5 | 0.34% | 1.23% | 2.22% | Q1 2018 | Q3 2023 | 19 |
| BAX | BAXTER INTL INC | 6 | 1 | 0.09% | 1.02% | 4.30% | Q1 2015 | Q1 2023 | 19 |
| OXFD | OXFORD IMMUNOTEC GLOBA... | 18 | 18 | 0.10% | 3.60% | 14.11% | Q3 2016 | Q4 2020 | 18 |
| ABT | ABBOTT LABS | 16 | 1 | 0.27% | 2.66% | 6.76% | Q4 2014 | Q3 2023 | 18 |
| UNH | UNITEDHEALTH GROUP INC | 17 | 17 | 0.82% | 2.54% | 3.63% | Q4 2014 | Q4 2018 | 17 |
| HCA | HCA HOLDINGS INC | 10 | 1 | 0.12% | 1.67% | 6.47% | Q4 2014 | Q4 2022 | 17 |
| SYK | STRYKER CORPORATION | 13 | 1 | 0.25% | 1.67% | 3.09% | Q4 2014 | Q3 2023 | 17 |
| CELG | CELGENE CORP | 17 | 17 | 0.46% | 1.64% | 5.71% | Q4 2014 | Q4 2018 | 17 |
| INSM | INSMED INC | 15 | 2 | 0.21% | 1.15% | 2.04% | Q3 2017 | Q3 2023 | 17 |
| NVRO | NEVRO CORP | 15 | 1 | 0.23% | 0.81% | 1.63% | Q2 2015 | Q1 2021 | 17 |
| AGN | ALLERGAN PLC | 16 | 16 | 1.06% | 4.37% | 8.41% | Q2 2015 | Q1 2019 | 16 |
| MRK | MERCK & CO INC NEW | 6 | 1 | 0.12% | 2.67% | 6.79% | Q4 2014 | Q3 2023 | 16 |
| TEVA | TEVA PHARMACEUTICAL IN... | 12 | 1 | 0.10% | 2.55% | 7.24% | Q4 2014 | Q1 2023 | 16 |
| AET | AETNA INC NEW | 16 | 16 | 0.67% | 2.43% | 3.84% | Q4 2014 | Q3 2018 | 16 |
| MDT | MEDTRONIC PLC | 9 | 1 | 0.38% | 2.35% | 4.63% | Q1 2015 | Q2 2023 | 16 |
| WMGI | WRIGHT MED GROUP N V | 10 | 6 | 0.11% | 2.01% | 4.37% | Q4 2015 | Q4 2019 | 16 |
| CVS | CVS HEALTH CORP | 14 | 1 | 0.24% | 1.62% | 5.11% | Q2 2015 | Q1 2021 | 16 |
| MYL | MYLAN N V | 16 | 16 | 0.19% | 1.40% | 2.82% | Q1 2015 | Q4 2018 | 16 |
| CI | CIGNA CORPORATION | 16 | 16 | 0.08% | 1.39% | 7.67% | Q4 2014 | Q3 2018 | 16 |
| SELB | SELECTA BIOSCIENCES INC | 16 | 16 | 0.02% | 1.08% | 2.12% | Q4 2019 | Q3 2023 | 16 |
| FATE | FATE THERAPEUTICS INC | 8 | 3 | 0.12% | 0.76% | 2.18% | Q3 2017 | Q2 2022 | 16 |
| BMY | BRISTOL-MYERS SQUIBB CO | 13 | 1 | 0.12% | 3.73% | 8.12% | Q3 2018 | Q3 2022 | 15 |
| WBA | WALGREENS BOOTS ALLIAN... | 12 | 3 | 0.12% | 1.85% | 4.00% | Q4 2014 | Q3 2018 | 15 |
| ESRX | EXPRESS SCRIPTS HLDG CO | 15 | 15 | 0.35% | 1.71% | 2.73% | Q1 2015 | Q3 2018 | 15 |
| ZTS | ZOETIS INC | 7 | 3 | 0.27% | 1.50% | 4.01% | Q1 2017 | Q2 2023 | 15 |
| GILD | GILEAD SCIENCES INC | 8 | 1 | 0.24% | 1.36% | 4.00% | Q4 2014 | Q1 2019 | 15 |
| HRC | HILL ROM HLDGS INC | 6 | 2 | 0.21% | 1.32% | 3.22% | Q4 2014 | Q2 2020 | 15 |
| XRAY | DENTSPLY SIRONA INC | 3 | 1 | 0.08% | 1.05% | 2.33% | Q3 2016 | Q1 2023 | 15 |
| ADAP | ADAPTIMMUNE THERAPEUTI... | 15 | 15 | 0.20% | 0.97% | 2.10% | Q1 2020 | Q3 2023 | 15 |
| SHPG | SHIRE PLC | 14 | 14 | 0.61% | 3.71% | 7.27% | Q3 2015 | Q4 2018 | 14 |
| UHS | UNIVERSAL HLTH SVCS INC | 8 | 1 | 0.12% | 2.33% | 3.81% | Q4 2014 | Q2 2020 | 14 |
| ABBV | ABBVIE INC | 6 | 1 | 0.12% | 2.27% | 5.15% | Q4 2014 | Q3 2021 | 14 |
| EHC | ENCOMPASS HEALTH CORP | 8 | 1 | 0.27% | 2.07% | 5.31% | Q4 2018 | Q2 2023 | 14 |
| A | AGILENT TECHNOLOGIES INC | 8 | 1 | 0.14% | 1.01% | 4.80% | Q4 2014 | Q2 2023 | 14 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 6 | 2 | 0.18% | 0.93% | 2.56% | Q3 2018 | Q1 2023 | 14 |
| BIIB | BIOGEN INC | 13 | 13 | 0.99% | 1.92% | 3.78% | Q4 2014 | Q4 2017 | 13 |
| BIO | BIO RAD LABS INC | 9 | 2 | 0.09% | 1.63% | 3.10% | Q2 2019 | Q1 2023 | 13 |
| CAH | CARDINAL HEALTH INC | 7 | 1 | 0.14% | 1.38% | 2.62% | Q4 2014 | Q2 2023 | 13 |
| CRL | CHARLES RIV LABS INTL INC | 8 | 1 | 0.14% | 0.90% | 3.56% | Q3 2015 | Q4 2022 | 13 |
| MNKKQ | MALLINCKRODT PUB LTD CO | 11 | 1 | 0.22% | 2.31% | 5.53% | Q4 2014 | Q2 2018 | 12 |
| PFE | PFIZER INC | 4 | 1 | 0.38% | 2.00% | 7.55% | Q4 2014 | Q1 2023 | 12 |
| ACRS | ACLARIS THERAPEUTICS INC | 11 | 1 | 0.15% | 1.16% | 2.99% | Q1 2019 | Q1 2023 | 12 |
| SRPT | SAREPTA THERAPEUTICS INC | 5 | 1 | 0.10% | 0.81% | 1.74% | Q4 2016 | Q4 2021 | 12 |
| AZN | ASTRAZENECA PLC | 5 | 2 | 0.50% | 3.11% | 5.87% | Q2 2019 | Q3 2023 | 11 |
| RCM | R1 RCM INC | 7 | 4 | 0.70% | 2.75% | 7.62% | Q3 2018 | Q4 2021 | 11 |
| HLS | HEALTHSOUTH CORP | 9 | 2 | 0.31% | 2.69% | 4.76% | Q4 2014 | Q3 2017 | 11 |
| SIBN | SI-BONE INC | 5 | 1 | 0.35% | 2.61% | 7.16% | Q2 2019 | Q2 2022 | 11 |
| THC | TENET HEALTHCARE CORP | 10 | 1 | 0.80% | 2.22% | 4.12% | Q1 2019 | Q3 2023 | 11 |
| AVTR | AVANTOR INC | 8 | 1 | 0.48% | 2.18% | 4.92% | Q1 2020 | Q3 2023 | 11 |
| BCR | BARD C R INC | 7 | 4 | 0.13% | 1.78% | 3.64% | Q4 2014 | Q3 2017 | 11 |
| FLDM | FLUIDIGM CORP DEL | 5 | 3 | 0.27% | 0.96% | 1.88% | Q2 2015 | Q1 2020 | 11 |
| VRTX | VERTEX PHARMACEUTICALS... | 8 | 1 | 0.17% | 0.59% | 1.20% | Q4 2014 | Q1 2022 | 11 |
| VRX | VALEANT PHARMACEUTICAL... | 8 | 1 | 0.07% | 0.58% | 1.44% | Q4 2014 | Q2 2018 | 11 |
| INCY | INCYTE CORP | 10 | 1 | 0.18% | 0.48% | 0.84% | Q4 2015 | Q2 2022 | 11 |
| AXSM | AXSOME THERAPEUTICS INC | 4 | 1 | 0.15% | 0.43% | 1.09% | Q3 2018 | Q3 2023 | 11 |
| OCRX | OCERA THERAPEUTICS INC | 11 | 11 | 0.04% | 0.18% | 0.52% | Q4 2014 | Q2 2017 | 11 |
| SPY | SPDR S&P 500 ETF TR | 4 | 1 | 1.31% | 8.63% | 23.70% | Q1 2019 | Q2 2023 | 10 |
| BMRN | BIOMARIN PHARMACEUTICA... | 6 | 1 | 0.14% | 4.04% | 14.27% | Q1 2017 | Q3 2023 | 10 |
| ICLR | ICON PLC | 4 | 1 | 0.37% | 3.24% | 5.45% | Q1 2018 | Q1 2023 | 10 |
| SNY | SANOFI | 2 | 1 | 0.28% | 2.57% | 8.12% | Q4 2014 | Q4 2021 | 10 |
| SYNH | SYNEOS HEALTH INC | 8 | 2 | 0.17% | 1.94% | 3.20% | Q1 2018 | Q1 2022 | 10 |
| AHCO | ADAPTHEALTH CORP | 6 | 1 | 0.06% | 1.49% | 3.83% | Q4 2019 | Q3 2023 | 10 |
| TRILLIUM THERAPEUTICS INC | 6 | 4 | 0.04% | 0.95% | 3.48% | Q4 2015 | Q2 2021 | 10 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 6 | 1 | 0.20% | 0.94% | 2.85% | Q1 2015 | Q3 2018 | 10 |
| NSTG | NANOSTRING TECHNOLOGIE... | 4 | 3 | 0.38% | 0.92% | 2.38% | Q4 2014 | Q3 2017 | 10 |
| ALBO | ALBIREO PHARMA INC | 10 | 10 | 0.26% | 0.84% | 1.91% | Q3 2020 | Q4 2022 | 10 |
| PBYI | PUMA BIOTECHNOLOGY INC | 7 | 3 | 0.13% | 0.52% | 1.05% | Q4 2014 | Q3 2018 | 10 |
| ARRY | ARRAY BIOPHARMA INC | 8 | 2 | 0.02% | 0.36% | 0.77% | Q3 2016 | Q1 2019 | 10 |
| STJ | ST JUDE MED INC | 9 | 9 | 1.17% | 3.09% | 5.17% | Q4 2014 | Q4 2016 | 9 |
| AZYO | AZIYO BIOLOGICS INC | 9 | 9 | 1.51% | 2.11% | 2.81% | Q4 2020 | Q4 2022 | 9 |
| SPNC | SPECTRANETICS CORP | 9 | 9 | 0.10% | 1.24% | 2.80% | Q4 2014 | Q4 2016 | 9 |
| PKI | PERKINELMER INC | 2 | 1 | 0.21% | 0.79% | 1.43% | Q4 2014 | Q4 2021 | 9 |
| REGN | REGENERON PHARMACEUTICALS | 3 | 1 | 0.14% | 0.76% | 3.24% | Q3 2015 | Q2 2021 | 9 |
| STRO | SUTRO BIOPHARMA INC | 5 | 1 | 0.07% | 0.67% | 1.37% | Q4 2019 | Q4 2022 | 9 |
| EW | EDWARDS LIFESCIENCES CORP | 5 | 1 | 0.13% | 0.54% | 1.38% | Q2 2015 | Q1 2022 | 9 |
| FOLD | AMICUS THERAPEUTICS INC | 5 | 4 | 0.12% | 0.46% | 0.91% | Q3 2016 | Q4 2018 | 9 |
| ILMN | ILLUMINA INC | 4 | 2 | 0.18% | 0.40% | 0.59% | Q4 2014 | Q2 2017 | 9 |
| PARNF | PARNELL PHARMACEUT HLD... | 9 | 9 | 0.09% | 0.37% | 0.60% | Q4 2014 | Q4 2016 | 9 |
| TVTY | TIVITY HEALTH INC | 7 | 1 | 0.30% | 1.82% | 4.44% | Q1 2017 | Q1 2019 | 8 |
| MTEM | MOLECULAR TEMPLATES INC | 8 | 8 | 0.17% | 1.16% | 2.33% | Q2 2020 | Q1 2022 | 8 |
| CTLT | CATALENT INC | 4 | 1 | 0.20% | 1.06% | 3.30% | Q2 2015 | Q1 2023 | 8 |
| CNMD | CONMED CORP | 2 | 1 | 0.27% | 1.05% | 3.80% | Q1 2016 | Q3 2023 | 8 |
| CLVS | CLOVIS ONCOLOGY INC | 8 | 8 | 0.11% | 0.75% | 1.42% | Q3 2016 | Q2 2018 | 8 |
| AERI | AERIE PHARMACEUTICALS INC | 8 | 8 | 0.17% | 0.61% | 0.98% | Q1 2016 | Q4 2017 | 8 |
| AMGN | AMGEN INC | 4 | 1 | 0.11% | 0.60% | 1.34% | Q1 2015 | Q1 2020 | 8 |
| VKTX | VIKING THERAPEUTICS INC | 5 | 3 | 0.19% | 0.54% | 1.65% | Q1 2018 | Q2 2023 | 8 |
| IMUX | IMMUNIC INC | 8 | 8 | 0.04% | 0.47% | 0.76% | Q3 2020 | Q2 2022 | 8 |
| SENSEONICS HLDGS INC | 8 | 8 | 0.07% | 0.40% | 0.67% | Q1 2019 | Q4 2020 | 8 | |
| DERM | DERMIRA INC | 8 | 8 | 0.09% | 0.33% | 0.63% | Q4 2015 | Q3 2017 | 8 |
| RAD | RITE AID CORP | 8 | 8 | 0.05% | 0.28% | 0.63% | Q4 2014 | Q3 2016 | 8 |
| INVACARE CORP | 5 | 2 | 5.04% | 13.42% | 19.78% | Q1 2021 | Q4 2022 | 7 | |
| SBRA | SABRA HEALTH CARE REIT... | 4 | 1 | 0.86% | 3.10% | 6.89% | Q3 2017 | Q3 2023 | 7 |
| QGEN | QIAGEN NV | 6 | 1 | 0.25% | 2.74% | 6.59% | Q1 2018 | Q2 2023 | 7 |
| DHR | DANAHER CORP DEL | 3 | 1 | 0.47% | 1.53% | 3.58% | Q4 2014 | Q3 2018 | 7 |
| FLUIDIGM CORP DEL | 4 | 3 | 0.19% | 1.46% | 3.31% | Q4 2016 | Q2 2019 | 7 | |
| MD | MEDNAX INC | 5 | 1 | 0.18% | 1.18% | 2.97% | Q2 2016 | Q2 2019 | 7 |
| BBH | VANECK VECTORS ETF TR | 7 | 7 | 0.26% | 1.10% | 1.90% | Q2 2016 | Q4 2017 | 7 |
| HAE | HAEMONETICS CORP MASS | 2 | 1 | 0.14% | 0.92% | 2.16% | Q1 2019 | Q4 2021 | 7 |
| TNDM | TANDEM DIABETES CARE INC | 7 | 7 | 0.27% | 0.79% | 1.44% | Q1 2015 | Q3 2016 | 7 |
| FVE | FIVE STAR QUALITY CARE... | 7 | 7 | 0.12% | 0.73% | 1.66% | Q1 2015 | Q3 2016 | 7 |
| XENT | INTERSECT ENT INC | 3 | 2 | 0.07% | 0.65% | 2.43% | Q1 2015 | Q3 2019 | 7 |
| PRTA | PROTHENA CORP PLC | 6 | 1 | 0.23% | 0.57% | 1.24% | Q1 2017 | Q4 2020 | 7 |
| AMPH | AMPHASTAR PHARMACEUTIC... | 7 | 7 | 0.26% | 0.55% | 0.75% | Q4 2014 | Q2 2016 | 7 |
| CSLT | CASTLIGHT HEALTH INC | 7 | 7 | 0.10% | 0.52% | 1.01% | Q1 2015 | Q3 2016 | 7 |
| PTCT | PTC THERAPEUTICS INC | 3 | 1 | 0.06% | 0.37% | 1.32% | Q2 2015 | Q1 2023 | 7 |
| SSRG | SYMMETRY SURGICAL INC | 7 | 7 | 0.15% | 0.29% | 0.44% | Q4 2014 | Q2 2016 | 7 |
| GMED | GLOBUS MED INC | 6 | 6 | 0.42% | 2.52% | 4.98% | Q4 2014 | Q1 2016 | 6 |
| PRAH | PRA HEALTH SCIENCES INC | 4 | 1 | 0.61% | 2.24% | 4.52% | Q2 2018 | Q4 2020 | 6 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 3 | 1 | 0.66% | 1.66% | 3.22% | Q2 2017 | Q4 2019 | 6 |
| EVHC | ENVISION HEALTHCARE CORP | 6 | 6 | 0.92% | 1.58% | 2.53% | Q4 2016 | Q1 2018 | 6 |
| IQV | IQVIA HLDGS INC | 3 | 1 | 0.12% | 1.47% | 3.76% | Q2 2018 | Q3 2023 | 6 |
| AMAG | AMAG PHARMACEUTICALS INC | 5 | 1 | 0.18% | 1.03% | 2.01% | Q1 2015 | Q3 2016 | 6 |
| OMI | OWENS & MINOR INC NEW | 5 | 1 | 0.24% | 0.92% | 1.99% | Q4 2020 | Q3 2022 | 6 |
| PTLA | PORTOLA PHARMACEUTICAL... | 5 | 1 | 0.12% | 0.81% | 1.64% | Q3 2015 | Q2 2018 | 6 |
| KTWO | K2M GROUP HLDGS INC | 3 | 1 | 0.39% | 0.80% | 1.19% | Q1 2015 | Q2 2017 | 6 |
| PODD | INSULET CORP | 2 | 1 | 0.03% | 0.75% | 1.71% | Q1 2015 | Q3 2023 | 6 |
| LQDA | LIQUIDIA TECHNOLOGIES INC | 6 | 6 | 0.29% | 0.69% | 1.48% | Q3 2018 | Q4 2019 | 6 |
| BKD | BROOKDALE SR LIVING INC | 5 | 1 | 0.26% | 0.67% | 1.25% | Q3 2015 | Q2 2017 | 6 |
| GI | ENDOCHOICE HLDGS INC | 6 | 6 | 0.22% | 0.65% | 1.58% | Q2 2015 | Q3 2016 | 6 |
| XBI | SPDR SER TR | 3 | 3 | 0.07% | 0.59% | 1.32% | Q1 2017 | Q2 2022 | 6 |
| ENDOLOGIX INC | 6 | 6 | 0.42% | 0.53% | 0.66% | Q2 2017 | Q3 2018 | 6 | |
| HZNP | HORIZON PHARMA PLC | 5 | 1 | 0.18% | 0.41% | 0.80% | Q1 2015 | Q3 2016 | 6 |
| NBIX | NEUROCRINE BIOSCIENCES... | 4 | 1 | 0.17% | 0.33% | 0.96% | Q2 2015 | Q2 2022 | 6 |
| ZGNX | ZOGENIX INC | 3 | 1 | 0.04% | 0.32% | 0.66% | Q4 2017 | Q4 2021 | 6 |
| ARA | AMERICAN RENAL ASSOCIA... | 4 | 1 | 0.08% | 0.32% | 0.50% | Q2 2016 | Q3 2018 | 6 |
| MRVI | MARAVAI LIFESCIENCES H... | 4 | 1 | 0.12% | 0.26% | 0.54% | Q1 2021 | Q1 2023 | 6 |
| IMGN | IMMUNOGEN INC | 3 | 1 | 0.18% | 0.26% | 0.41% | Q2 2017 | Q1 2019 | 6 |
| ANAB | ANAPTYSBIO INC | 3 | 1 | 0.08% | 0.23% | 0.43% | Q1 2017 | Q1 2019 | 6 |
| RDUS | RADIUS HEALTH INC | 4 | 2 | 0.10% | 0.22% | 0.40% | Q2 2016 | Q1 2018 | 6 |
| NVLS | NIVALIS THERAPEUTICS INC | 6 | 6 | 0.04% | 0.14% | 0.26% | Q2 2015 | Q3 2016 | 6 |
| TAK | TAKEDA PHARMACEUTICAL ... | 3 | 1 | 0.57% | 3.27% | 6.51% | Q1 2019 | Q3 2022 | 5 |
| INVACARE CORP | 5 | 5 | 2.31% | 2.85% | 3.44% | Q4 2021 | Q4 2022 | 5 | |
| IIN | INTRICON CORP | 5 | 5 | 0.51% | 2.79% | 5.48% | Q3 2018 | Q3 2019 | 5 |
| EVOLENT HEALTH INC | 5 | 5 | 0.97% | 2.62% | 4.20% | Q2 2019 | Q2 2020 | 5 | |
| KIDS | ORTHOPEDIATRICS CORP | 3 | 2 | 0.41% | 2.41% | 5.04% | Q3 2020 | Q3 2023 | 5 |
| MDRX | ALLSCRIPTS HEALTHCARE ... | 2 | 1 | 0.48% | 1.49% | 3.01% | Q4 2014 | Q4 2019 | 5 |
| ATRC | ATRICURE INC | 3 | 1 | 0.31% | 1.32% | 2.82% | Q1 2019 | Q4 2021 | 5 |
| PHAS | PHASEBIO PHARMACEUTICA... | 5 | 5 | 0.08% | 1.05% | 2.18% | Q1 2021 | Q1 2022 | 5 |
| DARIOHEALTH CORP | 5 | 5 | 0.11% | 0.80% | 1.60% | Q1 2021 | Q1 2022 | 5 | |
| TFX | TELEFLEX INCORPORATED | 3 | 1 | 0.34% | 0.79% | 1.78% | Q4 2014 | Q2 2021 | 5 |
| BLUE | BLUEBIRD BIO INC | 3 | 2 | 0.17% | 0.57% | 0.86% | Q1 2015 | Q3 2023 | 5 |
| MDVN | MEDIVATION INC | 3 | 2 | 0.19% | 0.51% | 0.88% | Q4 2014 | Q1 2016 | 5 |
| PRAX | PRAXIS PRECISION MEDIC... | 5 | 5 | 0.07% | 0.47% | 1.00% | Q2 2021 | Q2 2022 | 5 |
| NXTM | NXSTAGE MEDICAL INC | 2 | 1 | 0.13% | 0.44% | 0.77% | Q1 2015 | Q3 2018 | 5 |
| RXDX | IGNYTA INC | 3 | 2 | 0.04% | 0.24% | 0.60% | Q2 2016 | Q3 2017 | 5 |
| ALRN | AILERON THERAPEUTICS INC | 4 | 1 | 0.10% | 0.23% | 0.28% | Q2 2017 | Q3 2020 | 5 |
| NLNK | NEWLINK GENETICS CORP | 3 | 2 | 0.11% | 0.23% | 0.46% | Q2 2016 | Q3 2017 | 5 |
| ALDR | ALDER BIOPHARMACEUTICA... | 3 | 2 | 0.08% | 0.21% | 0.34% | Q2 2016 | Q3 2017 | 5 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 4 | 1 | 0.09% | 0.21% | 0.33% | Q4 2016 | Q1 2019 | 5 |
| GNCA | GENOCEA BIOSCIENCES INC | 5 | 5 | 0.02% | 0.20% | 0.45% | Q2 2019 | Q2 2020 | 5 |
| HWAY | HEALTHWAYS INC | 5 | 5 | 0.07% | 0.19% | 0.28% | Q2 2015 | Q2 2016 | 5 |
| AKTX | AKARI THERAPEUTICS PLC | 4 | 1 | 0.13% | 0.18% | 0.27% | Q4 2017 | Q4 2020 | 5 |
| ONCE | SPARK THERAPEUTICS INC | 4 | 1 | 0.07% | 0.15% | 0.30% | Q1 2016 | Q2 2017 | 5 |
| BDSX | BIODESIX INC | 5 | 5 | 0.05% | 0.08% | 0.12% | Q1 2022 | Q1 2023 | 5 |
| AMSG | AMSURG CORP | 3 | 1 | 0.41% | 1.81% | 3.67% | Q4 2014 | Q3 2016 | 4 |
| ARGX | ARGENX SE | 3 | 1 | 0.37% | 1.61% | 4.02% | Q1 2022 | Q3 2023 | 4 |
| LLY | LILLY ELI & CO | 3 | 1 | 0.22% | 1.47% | 4.04% | Q4 2016 | Q3 2022 | 4 |
| CYH | COMMUNITY HEALTH SYS I... | 2 | 1 | 0.14% | 1.44% | 3.58% | Q4 2014 | Q4 2021 | 4 |
| VWR | VWR CORP | 3 | 1 | 0.79% | 1.40% | 2.33% | Q1 2016 | Q1 2017 | 4 |
| EVHC | ENVISION HEALTHCARE HL... | 2 | 2 | 0.38% | 1.20% | 2.37% | Q4 2014 | Q2 2016 | 4 |
| VCYT | VERACYTE INC | 3 | 1 | 0.59% | 1.19% | 1.78% | Q2 2021 | Q3 2022 | 4 |
| DGX | QUEST DIAGNOSTICS INC | 1 | 1 | 0.49% | 1.15% | 2.18% | Q4 2014 | Q3 2020 | 4 |
| ESPR | ESPERION THERAPEUTICS ... | 4 | 4 | 0.41% | 1.09% | 1.94% | Q2 2020 | Q1 2021 | 4 |
| ISRG | INTUITIVE SURGICAL INC | 3 | 1 | 0.25% | 1.03% | 1.37% | Q4 2014 | Q1 2022 | 4 |
| GWPH | GW PHARMACEUTICALS PLC | 4 | 4 | 0.67% | 0.90% | 1.24% | Q2 2019 | Q1 2020 | 4 |
| AKRXQ | AKORN INC | 4 | 4 | 0.21% | 0.89% | 1.22% | Q3 2016 | Q2 2017 | 4 |
| GDRX | GOODRX HLDGS INC | 2 | 1 | 0.44% | 0.87% | 1.39% | Q4 2020 | Q3 2023 | 4 |
| CALT | CALLIDITAS THERAPEUTIC... | 2 | 2 | 0.20% | 0.80% | 1.17% | Q2 2020 | Q2 2021 | 4 |
| KND | KINDRED HEALTHCARE INC | 4 | 4 | 0.42% | 0.75% | 1.21% | Q4 2014 | Q3 2015 | 4 |
| KMPH | KEMPHARM INC | 4 | 4 | 0.41% | 0.67% | 0.80% | Q2 2015 | Q1 2016 | 4 |
| PEN | PENUMBRA INC | 4 | 4 | 0.20% | 0.55% | 1.30% | Q1 2016 | Q4 2016 | 4 |
| ETNB | 89BIO INC | 4 | 4 | 0.15% | 0.49% | 1.14% | Q4 2022 | Q3 2023 | 4 |
| GRTS | GRITSTONE ONCOLOGY INC | 2 | 2 | 0.11% | 0.48% | 0.77% | Q1 2019 | Q1 2023 | 4 |
| ACHC | ACADIA HEALTHCARE COMP... | 1 | 1 | 0.27% | 0.48% | 0.64% | Q4 2016 | Q2 2023 | 4 |
| MGNX | MACROGENICS INC | 2 | 1 | 0.23% | 0.44% | 0.72% | Q3 2018 | Q3 2020 | 4 |
| BDSI | BIODELIVERY SCIENCES I... | 4 | 4 | 0.04% | 0.31% | 0.69% | Q1 2015 | Q4 2015 | 4 |
| MDCO | MEDICINES CO | 2 | 2 | 0.21% | 0.31% | 0.38% | Q3 2016 | Q1 2018 | 4 |
| ALGN | ALIGN TECHNOLOGY INC | 2 | 2 | 0.07% | 0.30% | 0.74% | Q1 2015 | Q2 2019 | 4 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 2 | 1 | 0.08% | 0.23% | 0.48% | Q4 2017 | Q1 2022 | 4 |
| TRNX | TORNIER N V | 4 | 4 | 0.16% | 0.23% | 0.34% | Q4 2014 | Q3 2015 | 4 |
| EXEL | EXELIXIS INC | 4 | 4 | 0.07% | 0.20% | 0.38% | Q3 2016 | Q2 2017 | 4 |
| ACAD | ACADIA PHARMACEUTICALS... | 3 | 1 | 0.11% | 0.18% | 0.30% | Q2 2015 | Q3 2018 | 4 |
| GLYC | GLYCOMIMETICS INC | 2 | 1 | 0.04% | 0.10% | 0.20% | Q4 2016 | Q2 2019 | 4 |
| VCRA | VOCERA COMMUNICATIONS INC | 2 | 1 | 0.30% | 2.58% | 4.89% | Q4 2017 | Q2 2019 | 3 |
| BRKR | BRUKER CORP | 2 | 1 | 0.15% | 2.45% | 6.23% | Q1 2015 | Q3 2023 | 3 |
| BXLT | BAXALTA INC | 3 | 3 | 1.58% | 2.25% | 2.87% | Q3 2015 | Q1 2016 | 3 |
| IART | INTEGRA LIFESCIENCES H... | 2 | 1 | 0.94% | 2.23% | 3.93% | Q2 2019 | Q3 2020 | 3 |
| XBI | SPDR SER TR | 3 | 3 | 0.30% | 2.22% | 3.28% | Q4 2021 | Q2 2022 | 3 |
| NVS | NOVARTIS A G | 3 | 3 | 1.22% | 1.94% | 2.59% | Q4 2014 | Q2 2015 | 3 |
| IVC | INVACARE CORP | 3 | 3 | 0.07% | 1.81% | 3.05% | Q1 2021 | Q3 2021 | 3 |
| SIEN | SIENTRA INC | 3 | 3 | 0.30% | 1.55% | 3.12% | Q1 2019 | Q3 2019 | 3 |
| BHC | BAUSCH HEALTH COS INC | 3 | 3 | 1.02% | 1.50% | 1.88% | Q3 2018 | Q1 2019 | 3 |
| OFIX | ORTHOFIX MED INC | 2 | 1 | 0.14% | 1.39% | 3.74% | Q3 2018 | Q1 2022 | 3 |
| DXCM | DEXCOM INC | 1 | 1 | 0.68% | 1.25% | 1.73% | Q2 2022 | Q3 2023 | 3 |
| GSK | GLAXOSMITHKLINE PLC | 3 | 3 | 0.53% | 1.23% | 1.78% | Q4 2016 | Q2 2017 | 3 |
| FLUIDIGM CORP DEL | 3 | 3 | 0.93% | 1.22% | 1.46% | Q1 2016 | Q3 2016 | 3 | |
| TXG | 10X GENOMICS INC | 1 | 1 | 0.45% | 1.19% | 2.63% | Q1 2022 | Q3 2023 | 3 |
| ENTL | ENTELLUS MED INC | 3 | 3 | 0.37% | 0.98% | 1.41% | Q2 2017 | Q4 2017 | 3 |
| MBIO | MUSTANG BIO INC | 3 | 3 | 0.13% | 0.89% | 1.33% | Q2 2020 | Q4 2020 | 3 |
| HSIC | SCHEIN HENRY INC | 1 | 1 | 0.25% | 0.87% | 1.33% | Q4 2016 | Q1 2019 | 3 |
| GLPG | GALAPAGOS NV | 3 | 3 | 0.71% | 0.86% | 1.01% | Q1 2022 | Q3 2022 | 3 |
| XRAY | DENTSPLY INTL INC NEW | 3 | 3 | 0.30% | 0.77% | 1.42% | Q1 2015 | Q3 2015 | 3 |
| MREO | MEREO BIOPHARMA GROUP PLC | 3 | 3 | 0.41% | 0.75% | 1.18% | Q1 2021 | Q3 2021 | 3 |
| APTOSE BIOSCIENCES INC | 3 | 3 | 0.61% | 0.72% | 0.81% | Q3 2020 | Q1 2021 | 3 | |
| MDVL | MEDAVAIL HOLDINGS INC | 3 | 3 | 0.34% | 0.72% | 0.98% | Q4 2020 | Q2 2021 | 3 |
| OSMT | OSMOTICA PHARMACEUTICA... | 3 | 3 | 0.40% | 0.71% | 0.95% | Q4 2018 | Q2 2019 | 3 |
| RGLS | REGULUS THERAPEUTICS INC | 3 | 3 | 0.56% | 0.70% | 0.97% | Q1 2021 | Q3 2021 | 3 |
| KNSA | KINIKSA PHARMACEUTICAL... | 2 | 1 | 0.53% | 0.69% | 0.85% | Q3 2020 | Q4 2021 | 3 |
| NTGN | NEON THERAPEUTICS INC | 3 | 3 | 0.12% | 0.69% | 1.09% | Q1 2019 | Q3 2019 | 3 |
| PETS | PETMED EXPRESS INC | 1 | 1 | 0.13% | 0.65% | 0.99% | Q4 2018 | Q3 2020 | 3 |
| ANGO | ANGIODYNAMICS INC | 2 | 1 | 0.12% | 0.64% | 1.02% | Q4 2020 | Q4 2021 | 3 |
| HALO | HALOZYME THERAPEUTICS INC | 3 | 3 | 0.50% | 0.61% | 0.73% | Q1 2017 | Q3 2017 | 3 |
| HMSY | HMS HLDGS CORP | 2 | 1 | 0.29% | 0.58% | 1.11% | Q3 2015 | Q2 2020 | 3 |
| RCUS | ARCUS BIOSCIENCES INC | 3 | 3 | 0.32% | 0.58% | 0.83% | Q1 2022 | Q3 2022 | 3 |
| ELOS | SYNERON MEDICAL LTD | 3 | 3 | 0.28% | 0.57% | 1.03% | Q1 2015 | Q3 2015 | 3 |
| OCR | OMNICARE INC | 3 | 3 | 0.12% | 0.57% | 0.95% | Q4 2014 | Q2 2015 | 3 |
| LMNX | LUMINEX CORP DEL | 1 | 1 | 0.08% | 0.57% | 1.10% | Q2 2017 | Q3 2020 | 3 |
| PDCO | PATTERSON COS INC | 1 | 1 | 0.18% | 0.56% | 1.16% | Q1 2017 | Q3 2021 | 3 |
| GBT | GLOBAL BLOOD THERAPEUT... | 3 | 3 | 0.30% | 0.54% | 0.91% | Q4 2021 | Q2 2022 | 3 |
| STE | STERIS PLC | 3 | 3 | 0.26% | 0.50% | 0.77% | Q2 2016 | Q4 2016 | 3 |
| PRNB | PRINCIPIA BIOPHARMA INC | 3 | 3 | 0.10% | 0.49% | 1.14% | Q4 2019 | Q2 2020 | 3 |
| TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 0.40% | 0.49% | 0.56% | Q2 2019 | Q1 2022 | 3 |
| ADVM | ADVERUM BIOTECHNOLOGIE... | 1 | 1 | 0.15% | 0.46% | 0.78% | Q3 2018 | Q4 2019 | 3 |
| ANIP | ANI PHARMACEUTICALS INC | 2 | 1 | 0.11% | 0.42% | 0.95% | Q3 2016 | Q3 2017 | 3 |
| MTD | METTLER TOLEDO INTERNA... | 1 | 1 | 0.13% | 0.42% | 0.64% | Q4 2014 | Q1 2022 | 3 |
| BLU | BELLUS HEALTH INC NEW | 3 | 3 | 0.31% | 0.40% | 0.54% | Q1 2021 | Q3 2021 | 3 |
| KRYS | KRYSTAL BIOTECH INC | 2 | 1 | 0.14% | 0.40% | 0.80% | Q4 2018 | Q3 2021 | 3 |
| NKTR | NEKTAR THERAPEUTICS | 2 | 1 | 0.17% | 0.40% | 0.80% | Q2 2017 | Q2 2018 | 3 |
| ICUI | ICU MED INC | 2 | 1 | 0.36% | 0.39% | 0.44% | Q2 2020 | Q1 2022 | 3 |
| AXGN | AXOGEN INC | 2 | 1 | 0.24% | 0.38% | 0.48% | Q3 2018 | Q3 2020 | 3 |
| PNTG | PENNANT GROUP INC | 2 | 1 | 0.16% | 0.36% | 0.53% | Q3 2020 | Q2 2021 | 3 |
| KITE | KITE PHARMA INC | 2 | 1 | 0.20% | 0.30% | 0.48% | Q3 2016 | Q3 2017 | 3 |
| SGMO | SANGAMO THERAPEUTICS INC | 2 | 1 | 0.14% | 0.30% | 0.41% | Q4 2014 | Q3 2018 | 3 |
| PMC | PHARMERICA CORP | 2 | 1 | 0.08% | 0.30% | 0.71% | Q1 2015 | Q2 2016 | 3 |
| PRGO | PERRIGO CO PLC | 3 | 3 | 0.15% | 0.30% | 0.52% | Q1 2016 | Q3 2016 | 3 |
| ZSAN | ZOSANO PHARMA CORP | 3 | 3 | 0.21% | 0.29% | 0.36% | Q1 2017 | Q3 2017 | 3 |
| ANAC | ANACOR PHARMACEUTICALS... | 3 | 3 | 0.21% | 0.27% | 0.33% | Q4 2014 | Q2 2015 | 3 |
| ALDX | ALDEYRA THERAPEUTICS INC | 3 | 3 | 0.08% | 0.27% | 0.43% | Q3 2018 | Q1 2019 | 3 |
| BLCM | BELLICUM PHARMACEUTICA... | 2 | 1 | 0.19% | 0.26% | 0.35% | Q4 2014 | Q2 2018 | 3 |
| HRTX | HERON THERAPEUTICS INC | 1 | 1 | 0.15% | 0.25% | 0.36% | Q4 2014 | Q4 2021 | 3 |
| WOOF | VCA INC | 2 | 1 | 0.11% | 0.24% | 0.50% | Q4 2014 | Q1 2016 | 3 |
| DPLO | DIPLOMAT PHARMACY INC | 2 | 1 | 0.12% | 0.24% | 0.44% | Q1 2016 | Q2 2017 | 3 |
| APLS | APELLIS PHARMACEUTICAL... | 2 | 1 | 0.12% | 0.17% | 0.19% | Q4 2017 | Q4 2019 | 3 |
| SNSS | SUNESIS PHARMACEUTICAL... | 3 | 3 | 0.05% | 0.14% | 0.26% | Q1 2015 | Q3 2015 | 3 |
| RGNX | REGENXBIO INC | 2 | 1 | 0.06% | 0.14% | 0.20% | Q3 2016 | Q2 2017 | 3 |
| ATNM | ACTINIUM PHARMACEUTICA... | 3 | 3 | 0.05% | 0.13% | 0.24% | Q2 2019 | Q4 2019 | 3 |
| ADCT | ADC THERAPEUTICS SA | 2 | 1 | 0.01% | 0.10% | 0.16% | Q2 2020 | Q2 2022 | 3 |
| B108PS | ACTAVIS PLC | 2 | 2 | 4.01% | 4.43% | 4.84% | Q4 2014 | Q1 2015 | 2 |
| OHI | OMEGA HEALTHCARE INVS INC | 1 | 1 | 2.38% | 2.70% | 3.01% | Q3 2022 | Q3 2023 | 2 |
| AVDR | AVEDRO INC | 2 | 2 | 2.14% | 2.46% | 2.77% | Q1 2019 | Q2 2019 | 2 |
| COO | COOPER COS INC | 1 | 1 | 0.96% | 2.13% | 3.29% | Q2 2018 | Q3 2023 | 2 |
| IWM | ISHARES TR | 1 | 1 | 0.64% | 2.10% | 3.57% | Q3 2020 | Q4 2021 | 2 |
| EVH | EVOLENT HEALTH INC | 1 | 1 | 1.70% | 1.89% | 2.08% | Q1 2019 | Q4 2019 | 2 |
| ASPX | AUSPEX PHARMACEUTICALS... | 2 | 2 | 1.11% | 1.54% | 1.96% | Q4 2014 | Q1 2015 | 2 |
| VTR | VENTAS INC | 1 | 1 | 1.12% | 1.42% | 1.72% | Q3 2022 | Q2 2023 | 2 |
| QQQ | INVESCO QQQ TR | 1 | 1 | 1.18% | 1.24% | 1.31% | Q1 2019 | Q2 2022 | 2 |
| LIVN | LIVANOVA PLC | 1 | 1 | 0.20% | 0.92% | 1.63% | Q3 2018 | Q1 2019 | 2 |
| PEAK | HEALTHPEAK PROPERTIES INC | 2 | 2 | 0.61% | 0.87% | 1.14% | Q4 2022 | Q1 2023 | 2 |
| PTI | PROTEOSTASIS THERAPEUT... | 2 | 2 | 0.84% | 0.85% | 0.86% | Q4 2017 | Q1 2018 | 2 |
| SLXP | SALIX PHARMACEUTICALS INC | 2 | 2 | 0.82% | 0.84% | 0.86% | Q4 2014 | Q1 2015 | 2 |
| INCR | INC RESH HLDGS INC | 1 | 1 | 0.16% | 0.83% | 1.50% | Q1 2017 | Q4 2017 | 2 |
| LHCG | LHC GROUP INC | 2 | 2 | 0.58% | 0.81% | 1.04% | Q2 2016 | Q3 2016 | 2 |
| MGLN | MAGELLAN HEALTH INC | 2 | 2 | 0.61% | 0.69% | 0.77% | Q4 2014 | Q1 2015 | 2 |
| MMSI | MERIT MED SYS INC | 2 | 2 | 0.38% | 0.66% | 0.94% | Q2 2022 | Q3 2022 | 2 |
| SBTX | SILVERBACK THERAPEUTIC... | 1 | 1 | 0.14% | 0.66% | 1.18% | Q2 2021 | Q4 2021 | 2 |
| MRNS | MARINUS PHARMACEUTICAL... | 2 | 2 | 0.59% | 0.66% | 0.72% | Q1 2019 | Q2 2019 | 2 |
| NUVA | NUVASIVE INC | 1 | 1 | 0.60% | 0.66% | 0.71% | Q1 2015 | Q2 2017 | 2 |
| SILK | SILK ROAD MEDICAL INC | 1 | 1 | 0.64% | 0.65% | 0.65% | Q4 2019 | Q4 2022 | 2 |
| NCNA | NUCANA PLC | 2 | 2 | 0.21% | 0.60% | 1.00% | Q3 2019 | Q4 2019 | 2 |
| WAT | WATERS CORP | 1 | 1 | 0.29% | 0.60% | 0.91% | Q1 2015 | Q2 2016 | 2 |
| ENDP | ENDO INTL PLC | 2 | 2 | 0.30% | 0.56% | 0.81% | Q3 2016 | Q4 2016 | 2 |
| ARAY | ACCURAY INC | 1 | 1 | 0.28% | 0.55% | 0.82% | Q4 2018 | Q4 2021 | 2 |
| SGRY | SURGERY PARTNERS INC | 2 | 2 | 0.17% | 0.55% | 0.92% | Q1 2019 | Q2 2019 | 2 |
| MASI | MASIMO CORP | 1 | 1 | 0.41% | 0.55% | 0.69% | Q1 2018 | Q2 2023 | 2 |
| AFMD | AFFIMED N V | 1 | 1 | 0.41% | 0.54% | 0.68% | Q1 2021 | Q1 2022 | 2 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2 | 2 | 0.32% | 0.48% | 0.65% | Q2 2023 | Q3 2023 | 2 |
| SRNE | SORRENTO THERAPEUTICS INC | 2 | 2 | 0.37% | 0.48% | 0.59% | Q4 2014 | Q1 2015 | 2 |
| TBIO | TRANSLATE BIO INC | 1 | 1 | 0.19% | 0.45% | 0.71% | Q2 2019 | Q3 2020 | 2 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.44% | 0.45% | 0.45% | Q1 2022 | Q4 2022 | 2 |
| PPH | VANECK VECTORS ETF TR | 1 | 1 | 0.34% | 0.44% | 0.54% | Q4 2016 | Q1 2018 | 2 |
| TARS | TARSUS PHARMACEUTICALS... | 1 | 1 | 0.12% | 0.44% | 0.76% | Q1 2021 | Q3 2023 | 2 |
| SDC | SMILEDIRECTCLUB INC | 2 | 2 | 0.16% | 0.41% | 0.66% | Q3 2019 | Q4 2019 | 2 |
| CANO | CANO HEALTH INC | 1 | 1 | 0.21% | 0.40% | 0.60% | Q2 2021 | Q3 2022 | 2 |
| RYTM | RHYTHM PHARMACEUTICALS... | 2 | 2 | 0.32% | 0.40% | 0.48% | Q4 2021 | Q1 2022 | 2 |
| FBRX | FORTE BIOSCIENCES INC | 2 | 2 | 0.25% | 0.37% | 0.49% | Q1 2021 | Q2 2021 | 2 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2 | 2 | 0.32% | 0.36% | 0.40% | Q4 2021 | Q1 2022 | 2 |
| AFFX | AFFYMETRIX INC | 1 | 1 | 0.31% | 0.34% | 0.38% | Q4 2014 | Q2 2015 | 2 |
| FPRX | FIVE PRIME THERAPEUTIC... | 2 | 2 | 0.08% | 0.33% | 0.59% | Q2 2020 | Q3 2020 | 2 |
| XENE | XENON PHARMACEUTICALS INC | 1 | 1 | 0.22% | 0.33% | 0.44% | Q1 2017 | Q3 2021 | 2 |
| CLDX | CELLDEX THERAPEUTICS I... | 2 | 2 | 0.14% | 0.33% | 0.52% | Q1 2015 | Q2 2015 | 2 |
| ASND | ASCENDIS PHARMA A S | 2 | 2 | 0.19% | 0.33% | 0.46% | Q3 2017 | Q4 2017 | 2 |
| ZLTQ | ZELTIQ AESTHETICS INC | 2 | 2 | 0.08% | 0.32% | 0.55% | Q4 2015 | Q1 2016 | 2 |
| VRAY | VIEWRAY INC | 1 | 1 | 0.28% | 0.30% | 0.32% | Q3 2018 | Q1 2019 | 2 |
| KERX | KERYX BIOPHARMACEUTICA... | 1 | 1 | 0.23% | 0.25% | 0.28% | Q3 2016 | Q1 2017 | 2 |
| XFOR | X4 PHARMACEUTICALS INC | 2 | 2 | 0.13% | 0.23% | 0.34% | Q1 2021 | Q2 2021 | 2 |
| AVDL | AVADEL PHARMACEUTICALS... | 1 | 1 | 0.15% | 0.23% | 0.32% | Q1 2018 | Q1 2020 | 2 |
| GOSS | GOSSAMER BIO INC | 2 | 2 | 0.16% | 0.23% | 0.31% | Q4 2021 | Q1 2022 | 2 |
| PCVX | VAXCYTE INC | 1 | 1 | 0.01% | 0.21% | 0.41% | Q2 2020 | Q3 2022 | 2 |
| BOLT | BOLT BIOTHERAPEUTICS INC | 1 | 1 | 0.15% | 0.21% | 0.26% | Q1 2021 | Q3 2021 | 2 |
| BOLD | AUDENTES THERAPEUTICS INC | 2 | 2 | 0.16% | 0.20% | 0.25% | Q2 2017 | Q3 2017 | 2 |
| CLSD | CLEARSIDE BIOMEDICAL INC | 2 | 2 | 0.14% | 0.20% | 0.26% | Q2 2018 | Q3 2018 | 2 |
| RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 0.19% | 0.20% | 0.20% | Q1 2018 | Q3 2022 | 2 |
| OMED | ONCOMED PHARMACEUTICAL... | 1 | 1 | 0.17% | 0.19% | 0.21% | Q4 2017 | Q3 2018 | 2 |
| STRM | STREAMLINE HEALTH SOLU... | 1 | 1 | 0.16% | 0.19% | 0.21% | Q2 2015 | Q1 2021 | 2 |
| CYAD | CELYAD ONCOLOGY SA | 2 | 2 | 0.14% | 0.18% | 0.23% | Q2 2021 | Q3 2021 | 2 |
| INBX | INHIBRX INC | 1 | 1 | 0.14% | 0.16% | 0.19% | Q3 2020 | Q4 2022 | 2 |
| CHRS | COHERUS BIOSCIENCES INC | 1 | 1 | 0.08% | 0.16% | 0.23% | Q3 2016 | Q1 2023 | 2 |
| CYTK | CYTOKINETICS INC | 2 | 2 | 0.14% | 0.15% | 0.16% | Q2 2022 | Q3 2022 | 2 |
| PCRX | PACIRA PHARMACEUTICALS... | 2 | 2 | 0.12% | 0.13% | 0.13% | Q2 2016 | Q3 2016 | 2 |
| MEIP | MEI PHARMA INC | 2 | 2 | 0.06% | 0.12% | 0.18% | Q4 2014 | Q1 2015 | 2 |
| ATNM | ACTINIUM PHARMACEUTICA... | 1 | 1 | 0.00% | 0.10% | 0.20% | Q4 2021 | Q4 2022 | 2 |
| ACOR | ACORDA THERAPEUTICS INC | 2 | 2 | 0.09% | 0.10% | 0.10% | Q1 2015 | Q2 2015 | 2 |
| DRNA | DICERNA PHARMACEUTICAL... | 1 | 1 | 0.05% | 0.07% | 0.10% | Q4 2017 | Q4 2019 | 2 |
| TEAR | TEARLAB CORP | 2 | 2 | 0.02% | 0.05% | 0.09% | Q4 2014 | Q1 2015 | 2 |
| ATNX | ATHENEX INC | 2 | 2 | 0.05% | 0.05% | 0.05% | Q3 2022 | Q4 2022 | 2 |
| PTI | PROTEOSTASIS THERAPEUT... | 1 | 1 | 0.03% | 0.05% | 0.06% | Q1 2019 | Q4 2019 | 2 |
| HSGX | HISTOGENICS CORP | 2 | 2 | 0.01% | 0.04% | 0.06% | Q2 2018 | Q3 2018 | 2 |
| IWN | ISHARES TR | 1 | 1 | 85.25% | 85.25% | 85.25% | Q2 2020 | Q2 2020 | 1 |
| INVACARE CORP | 1 | 1 | 11.66% | 11.66% | 11.66% | Q3 2021 | Q3 2021 | 1 | |
| TRILLIUM THERAPEUTICS INC | 1 | 1 | 8.27% | 8.27% | 8.27% | Q3 2021 | Q3 2021 | 1 | |
| BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 7.08% | 7.08% | 7.08% | Q2 2023 | Q2 2023 | 1 |
| ATNM | ACTINIUM PHARMACEUTICA... | 1 | 1 | 3.97% | 3.97% | 3.97% | Q1 2021 | Q1 2021 | 1 |
| MDT | MEDTRONIC INC | 1 | 1 | 2.95% | 2.95% | 2.95% | Q4 2014 | Q4 2014 | 1 |
| MRNA | MODERNA INC | 1 | 1 | 2.85% | 2.85% | 2.85% | Q1 2023 | Q1 2023 | 1 |
| SNN | SMITH & NEPHEW PLC | 1 | 1 | 2.72% | 2.72% | 2.72% | Q4 2020 | Q4 2020 | 1 |
| EAR | EARGO INC | 1 | 1 | 2.12% | 2.12% | 2.12% | Q2 2021 | Q2 2021 | 1 |
| SGEN | SEAGEN INC | 1 | 1 | 2.04% | 2.04% | 2.04% | Q2 2022 | Q2 2022 | 1 |
| QUIDELORTHO CORP | 1 | 1 | 1.76% | 1.76% | 1.76% | Q3 2023 | Q3 2023 | 1 | |
| XBI | SPDR SER TR | 1 | 1 | 1.71% | 1.71% | 1.71% | Q3 2020 | Q3 2020 | 1 |
| 5100PS | VOLCANO CORPORATION | 1 | 1 | 1.56% | 1.56% | 1.56% | Q4 2014 | Q4 2014 | 1 |
| INSMED INC | 1 | 1 | 1.52% | 1.52% | 1.52% | Q2 2021 | Q2 2021 | 1 | |
| AGN | ALLERGAN INC | 1 | 1 | 1.49% | 1.49% | 1.49% | Q4 2014 | Q4 2014 | 1 |
| XLV | SELECT SECTOR SPDR TR | 1 | 1 | 1.48% | 1.48% | 1.48% | Q1 2019 | Q1 2019 | 1 |
| INVACARE CORP | 1 | 1 | 1.41% | 1.41% | 1.41% | Q3 2021 | Q3 2021 | 1 | |
| ATR | APTARGROUP INC | 1 | 1 | 1.39% | 1.39% | 1.39% | Q3 2021 | Q3 2021 | 1 |
| ENTA | ENANTA PHARMACEUTICALS... | 1 | 1 | 1.33% | 1.33% | 1.33% | Q1 2015 | Q1 2015 | 1 |
| BNTX | BIONTECH SE | 1 | 1 | 1.32% | 1.32% | 1.32% | Q4 2022 | Q4 2022 | 1 |
| OCDX | ORTHO CLINICAL DIAGNOS... | 1 | 1 | 1.27% | 1.27% | 1.27% | Q4 2021 | Q4 2021 | 1 |
| MYL | MYLAN INC | 1 | 1 | 1.24% | 1.24% | 1.24% | Q4 2014 | Q4 2014 | 1 |
| AMICUS THERAPEUTICS INC | 1 | 1 | 1.19% | 1.19% | 1.19% | Q3 2017 | Q3 2017 | 1 | |
| F113PS | COVIDIEN PLC | 1 | 1 | 1.15% | 1.15% | 1.15% | Q4 2014 | Q4 2014 | 1 |
| TEVA | TEVA PHARMACEUTICAL IN... | 1 | 1 | 1.15% | 1.15% | 1.15% | Q2 2023 | Q2 2023 | 1 |
| VAPO | VAPOTHERM INC | 1 | 1 | 1.08% | 1.08% | 1.08% | Q3 2020 | Q3 2020 | 1 |
| QSII | QUALITY SYS INC | 1 | 1 | 1.03% | 1.03% | 1.03% | Q4 2014 | Q4 2014 | 1 |
| QGEN | QIAGEN NV | 1 | 1 | 0.95% | 0.95% | 0.95% | Q2 2015 | Q2 2015 | 1 |
| WAGE | WAGEWORKS INC | 1 | 1 | 0.94% | 0.94% | 0.94% | Q3 2017 | Q3 2017 | 1 |
| BRKS | AZENTA INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q3 2023 | Q3 2023 | 1 |
| VCEL | VERICEL CORP | 1 | 1 | 0.85% | 0.85% | 0.85% | Q1 2019 | Q1 2019 | 1 |
| IDXX | IDEXX LABS INC | 1 | 1 | 0.83% | 0.83% | 0.83% | Q1 2022 | Q1 2022 | 1 |
| MDAS | MEDASSETS INC | 1 | 1 | 0.82% | 0.82% | 0.82% | Q4 2014 | Q4 2014 | 1 |
| ISEE | IVERIC BIO INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q1 2023 | Q1 2023 | 1 |
| SEEL | SEELOS THERAPEUTICS INC | 1 | 1 | 0.80% | 0.80% | 0.80% | Q1 2021 | Q1 2021 | 1 |
| ELGX | ENDOLOGIX INC | 1 | 1 | 0.78% | 0.78% | 0.78% | Q1 2017 | Q1 2017 | 1 |
| SRCL | STERICYCLE INC | 1 | 1 | 0.77% | 0.77% | 0.77% | Q2 2016 | Q2 2016 | 1 |
| AXGT | AXOVANT SCIENCES LTD | 1 | 1 | 0.76% | 0.76% | 0.76% | Q1 2019 | Q1 2019 | 1 |
| EUCRU | EUCRATES BIOMEDICAL AC... | 1 | 1 | 0.75% | 0.75% | 0.75% | Q4 2020 | Q4 2020 | 1 |
| QURE | UNIQURE NV | 1 | 1 | 0.74% | 0.74% | 0.74% | Q1 2023 | Q1 2023 | 1 |
| RMD | RESMED INC | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2023 | Q1 2023 | 1 |
| PINC | PREMIER INC | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2022 | Q1 2022 | 1 |
| MEDP | MEDPACE HLDGS INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q4 2017 | Q4 2017 | 1 |
| INSP | INSPIRE MED SYS INC | 1 | 1 | 0.68% | 0.68% | 0.68% | Q3 2019 | Q3 2019 | 1 |
| ALC | ALCON AG | 1 | 1 | 0.65% | 0.65% | 0.65% | Q3 2020 | Q3 2020 | 1 |
| NTUS | NATUS MEDICAL INC DEL | 1 | 1 | 0.61% | 0.61% | 0.61% | Q2 2016 | Q2 2016 | 1 |
| GMTX | GEMINI THERAPEUTICS INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q1 2021 | Q1 2021 | 1 |
| AGRX | AGILE THERAPEUTICS INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q3 2017 | Q3 2017 | 1 |
| VENTYX BIOSCIENCES INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2023 | Q3 2023 | 1 | |
| TERN | TERNS PHARMACEUTICALS INC | 1 | 1 | 0.56% | 0.56% | 0.56% | Q4 2022 | Q4 2022 | 1 |
| KRTX | KARUNA THERAPEUTICS INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q1 2022 | Q1 2022 | 1 |
| ARWR | ARROWHEAD PHARMACEUTIC... | 1 | 1 | 0.46% | 0.46% | 0.46% | Q4 2022 | Q4 2022 | 1 |
| VREX | VAREX IMAGING CORP | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2017 | Q1 2017 | 1 |
| BCAB | BIOATLA INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q4 2022 | Q4 2022 | 1 |
| ARCELLX INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q3 2023 | Q3 2023 | 1 | |
| TCMD | TACTILE SYS TECHNOLOGY... | 1 | 1 | 0.45% | 0.45% | 0.45% | Q4 2017 | Q4 2017 | 1 |
| OPCH | OPTION CARE HEALTH INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q3 2022 | Q3 2022 | 1 |
| ARCT | ARCTURUS THERAPEUTICS ... | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2020 | Q3 2020 | 1 |
| SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q3 2020 | Q3 2020 | 1 |
| QTNT | QUOTIENT LTD | 1 | 1 | 0.43% | 0.43% | 0.43% | Q4 2020 | Q4 2020 | 1 |
| OFIX | ORTHOFIX INTL N V | 1 | 1 | 0.40% | 0.40% | 0.40% | Q2 2017 | Q2 2017 | 1 |
| AUPH | AURINIA PHARMACEUTICAL... | 1 | 1 | 0.37% | 0.37% | 0.37% | Q4 2021 | Q4 2021 | 1 |
| EGRX | EAGLE PHARMACEUTICALS INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2015 | Q1 2015 | 1 |
| PETQ | PETIQ INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q3 2019 | Q3 2019 | 1 |
| BTAI | BIOXCEL THERAPEUTICS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2023 | Q2 2023 | 1 |
| MOH | MOLINA HEALTHCARE INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q1 2019 | Q1 2019 | 1 |
| CRTX | CORTEXYME INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2020 | Q3 2020 | 1 |
| NRIX | NURIX THERAPEUTICS INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q4 2021 | Q4 2021 | 1 |
| DVA | DAVITA INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2022 | Q1 2022 | 1 |
| TDOC | TELADOC HEALTH INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q1 2019 | Q1 2019 | 1 |
| CDNA | CAREDX INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2022 | Q1 2022 | 1 |
| TLT | ISHARES TR | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2023 | Q3 2023 | 1 |
| NVST | ENVISTA HOLDINGS CORPO... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2023 | Q3 2023 | 1 |
| AXNX | AXONICS MODULATION TEC... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2019 | Q3 2019 | 1 |
| NTRA | NATERA INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2022 | Q1 2022 | 1 |
| KZR | KEZAR LIFE SCIENCES INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2022 | Q1 2022 | 1 |
| PRXL | PAREXEL INTL CORP | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2016 | Q3 2016 | 1 |
| TMCI | TREACE MED CONCEPTS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2021 | Q4 2021 | 1 |
| ALVR | ALLOVIR INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2021 | Q3 2021 | 1 |
| UHT | UNIVERSAL HEALTH RLTY ... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2015 | Q2 2015 | 1 |
| QDEL | QUIDEL CORP | 1 | 1 | 0.25% | 0.25% | 0.25% | Q4 2014 | Q4 2014 | 1 |
| NVTA | INVITAE CORP | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2017 | Q3 2017 | 1 |
| HZNP | HORIZON THERAPEUTICS P... | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2022 | Q2 2022 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2022 | Q4 2022 | 1 |
| GHDX | GENOMIC HEALTH INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2015 | Q2 2015 | 1 |
| IGMS | IGM BIOSCIENCES INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2022 | Q4 2022 | 1 |
| LDRH | LDR HLDG CORP | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2014 | Q4 2014 | 1 |
| SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2018 | Q3 2018 | 1 |
| CIVI | CIVITAS SOLUTIONS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2014 | Q4 2014 | 1 |
| PRVB | PROVENTION BIO INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2021 | Q2 2021 | 1 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2019 | Q1 2019 | 1 |
| ABOS | ACUMEN PHARMACEUTICALS... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2022 | Q3 2022 | 1 |
| MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2022 | Q3 2022 | 1 |
| PTX | PERNIX THERAPEUTICS HL... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2015 | Q2 2015 | 1 |
| RLMD | RELMADA THERAPEUTICS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2022 | Q3 2022 | 1 |
| ITOS | ITEOS THERAPEUTICS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2022 | Q4 2022 | 1 |
| DRAD | DIGIRAD CORP | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2014 | Q4 2014 | 1 |
| GNMK | GENMARK DIAGNOSTICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2015 | Q2 2015 | 1 |
| LCI | LANNET INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2017 | Q3 2017 | 1 |
| OVID | OVID THERAPEUTICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2020 | Q1 2020 | 1 |
| THOR | THORATEC CORP | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2015 | Q2 2015 | 1 |
| HGEN | HUMANIGEN INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2021 | Q4 2021 | 1 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2017 | Q4 2017 | 1 |
| TSRO | TESARO INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2016 | Q3 2016 | 1 |
| SLDB | SOLID BIOSCIENCES INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2020 | Q4 2020 | 1 |
| WCG | WELLCARE HEALTH PLANS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2015 | Q4 2015 | 1 |
| SIRO | SIRONA DENTAL SYSTEMS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2014 | Q4 2014 | 1 |
| BMEA | BIOMEA FUSION INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2022 | Q4 2022 | 1 |
| KDMN | KADMON HLDGS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2020 | Q1 2020 | 1 |
| RIGL | RIGEL PHARMACEUTICALS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2016 | Q3 2016 | 1 |
| BTAI | BIOXCEL THERAPEUTICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2023 | Q1 2023 | 1 |
| MOR | MORPHOSYS AG | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2022 | Q3 2022 | 1 |
| SPRO | SPERO THERAPEUTICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2017 | Q4 2017 | 1 |
| VAR | VARIAN MED SYS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2015 | Q2 2015 | 1 |
| IMGN | IMMUNOGEN INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2019 | Q1 2019 | 1 |
| CRVS | CORVUS PHARMACEUTICALS... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2017 | Q1 2017 | 1 |
| OYST | OYSTER PT PHARMA INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2022 | Q4 2022 | 1 |
| FSTX | F-STAR THERAPEUTICS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2020 | Q4 2020 | 1 |
| LBPH | LONGBOARD PHARMACEUTIC... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2021 | Q1 2021 | 1 |
| HTWR | HEARTWARE INTL INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2015 | Q3 2015 | 1 |
| ARWR | ARROWHEAD RESH CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2015 | Q1 2015 | 1 |
| ADXN | ADDEX THERAPEUTICS LTD | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2023 | Q1 2023 | 1 |
| CRBP | CORBUS PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2020 | Q3 2020 | 1 |
| TCRR | TCR2 THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2020 | Q2 2020 | 1 |
| ACRS | ACLARIS THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2019 | Q4 2019 | 1 |
| ATHENEX INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2023 | Q1 2023 | 1 | |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2020 | Q2 2020 | 1 |
| VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2023 | 1 |
Download | |||||||||
The securities at the top of the list , including LABORATORY CORP AMER HLDGS, ELEVANCE HEALTH INC, and BECTON DICKINSON & CO, are the highest-conviction holdings of Endurant Capital Management LP.
The conviction is calculated by counting the number of quarters a security has been reported by Endurant Capital Management LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Endurant Capital Management LP owns currently or has owned in the past.